<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>102(24)</volume><submitter>Aslan FM</submitter><pubmed_abstract>Streptavidin, a homotetrameric protein with extremely tight biotin binding (K(d) &lt; or = 10(-14) M), has been widely used as an affinity reagent. Its utility would be increased by engineering single-chain mutants with a wide spectrum of affinities, more suitable for phage-display and chip technologies. By a circular permutation procedure, we converted streptavidin to a single-chain dimer (SCD) with two biotin-binding sites and introduced random mutations by error-prone PCR. Clones from a phagemid library, expressed as gene-3 fusion proteins on M13 bacteriophage, were panned with biotinylated beads, and SCD genes from affinity-enriched phage were subcloned to produce soluble proteins. Purification of products from the original gene and two mutants by FPLC and analysis by MALDI-TOF MS showed they exist in both dimeric (single-chain) and tetrameric (two-chain) forms, which were further characterized for their binding affinity to biotin-4-fluorescein (B4F) by fluorescence polarization and intensity measurements. K'(d) values for B4F ranged from approximately 10(-11) to 10(-10) M, although K(d) values for biotin ranged from 10(-6) to 10(-5) M. These results point to the possibility of combining an SCD streptavidin mutant with B4F derivatives to create a fluorescence-tagged affinity system with tight but still-reversible interaction that could be used sequentially with ordinary streptavidin-biotin for composite separation or analysis steps.</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pagination>8507-12</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC1150841</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Engineered single-chain dimeric streptavidins with an unexpected strong preference for biotin-4-fluorescein.</pubmed_title><pmcid>PMC1150841</pmcid><pubmed_authors>Mohr SC</pubmed_authors><pubmed_authors>Cantor CR</pubmed_authors><pubmed_authors>Aslan FM</pubmed_authors><pubmed_authors>Yu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Engineered single-chain dimeric streptavidins with an unexpected strong preference for biotin-4-fluorescein.</name><description>Streptavidin, a homotetrameric protein with extremely tight biotin binding (K(d) &lt; or = 10(-14) M), has been widely used as an affinity reagent. Its utility would be increased by engineering single-chain mutants with a wide spectrum of affinities, more suitable for phage-display and chip technologies. By a circular permutation procedure, we converted streptavidin to a single-chain dimer (SCD) with two biotin-binding sites and introduced random mutations by error-prone PCR. Clones from a phagemid library, expressed as gene-3 fusion proteins on M13 bacteriophage, were panned with biotinylated beads, and SCD genes from affinity-enriched phage were subcloned to produce soluble proteins. Purification of products from the original gene and two mutants by FPLC and analysis by MALDI-TOF MS showed they exist in both dimeric (single-chain) and tetrameric (two-chain) forms, which were further characterized for their binding affinity to biotin-4-fluorescein (B4F) by fluorescence polarization and intensity measurements. K'(d) values for B4F ranged from approximately 10(-11) to 10(-10) M, although K(d) values for biotin ranged from 10(-6) to 10(-5) M. These results point to the possibility of combining an SCD streptavidin mutant with B4F derivatives to create a fluorescence-tagged affinity system with tight but still-reversible interaction that could be used sequentially with ordinary streptavidin-biotin for composite separation or analysis steps.</description><dates><release>2005-01-01T00:00:00Z</release><publication>2005 Jun</publication><modification>2024-11-06T14:32:56.66Z</modification><creation>2019-03-27T01:09:00Z</creation></dates><accession>S-EPMC1150841</accession><cross_references><pubmed>15939877</pubmed><doi>10.1073/pnas.0503112102</doi></cross_references></HashMap>